Tag: Emplicure

  • Up-and-Coming Nicotine Innovators

    Up-and-Coming Nicotine Innovators

    Emerging nicotine companies said regulatory barriers, consumer education and the infrastructure surrounding products are increasingly shaping innovation at GTNF 2026 in Lisbon. Anna Franzén, chief regulatory, clinical and quality officer at Emplicure Consumer AB, said consumer diversity is important and that companies need greater cross-functional cooperation. Ronan Barry, chief legal and corporate affairs officer at AIR, said the share of nicotine consumers using combustible cigarettes has fallen from roughly 90%-95% a decade ago to about half today. He said innovation still needs to match the results of traditional smoking while providing safer alternatives, but argued that regulatory requirements and compliance costs can give illicit operators an advantage.

    Fredrik Laurell, CEO of Nicoccino, said the industry has a responsibility to consumers who prefer nicotine to provide quality, safer products. He said overly restrictive regulations can create barriers for legitimate businesses while criminals face fewer obstacles, and called for greater cooperation between industry and regulators. Martin Miller, chief commercial officer at IKE, said innovation has shifted from the product itself to the infrastructure connecting consumers, products and regulation. He said manufacturers need to build regulatory considerations into products from the beginning rather than retrofit them later.

    Ryan Selby, managing director of Emerald Innovations, said nicotine adoption depends on more than the substance itself, with rituals and established consumer behaviors also influencing product use. He said heavily regulated markets limit opportunities to test new products and argued that companies need room to innovate while maintaining appropriate regulation. Selby also said limited consumer awareness remains a challenge, arguing that decades of public messaging about the risks of smoking have also contributed to misconceptions about nicotine. He said larger tobacco companies can play an important role in bringing new products to global markets.

  • Swedish Innovator Eyes U.S. Launch with Fast-Acting Nicotine Pouch

    Swedish Innovator Eyes U.S. Launch with Fast-Acting Nicotine Pouch

    As nicotine pouch use soars in the United States, Swedish biotech firm Emplicure AB announced plans to seek U.S. regulatory approval for its patented nicotine delivery system, Seratek. Designed to deliver nicotine more rapidly at lower strengths, the company says the technology could mark a new chapter in smokeless alternatives for adult nicotine users.

    According to a 2025 pharmacokinetic study, Seratek released 80% of its nicotine within five minutes under controlled conditions, outperforming existing pouch brands even at lower strengths. In a consumer taste test in Sweden, 123 adult pouch users preferred Seratek over international leaders for flavor, comfort, and discretion. Emplicure says it will file a Premarket Tobacco Application (PMTA) to authorize sales in the U.S.

    Emplicure CEO Mattias Josander, a former executive at Swedish Match, Red Bull, and L’Oréal, said the company’s goal is to “accelerate the transition to a smokeless world.” He added, “If vaccines were the breakthrough of the 20th century, nicotine pouches could represent the public-health breakthrough of the 21st.”